Literature DB >> 1109657

Intravenous salbutamol in management of status asthmaticus.

D H Fitchett, M W McNicol, J F Riordan.   

Abstract

After the administration of intravenous salbutamol (100-300 mug) to 11 patients admitted to hospital with a severe exacerbation of asthma there was a mean increase in peak expiratory flow of 44% accompanied by a rise in pulse rate of 24 beats/min. Blood gas tensions showed a trend to improvement and there were no serious side effects. It is concluded that intravenous salbutamol is an effective and apparently safe bronchodilator in the management of acutely ill patients with severe asthma.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1109657      PMCID： PMC1672258          DOI： 10.1136/bmj.1.5949.53

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  3 in total

1.  Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity.

Authors:  A E Tattersfield; M W McNicol
Journal:  N Engl J Med       Date:  1969-12-11       Impact factor: 91.245

2.  Intravenous corticosteroids in treatment of acute bronchial asthma.

Authors:  J V Collins; T J Clark; P W Harris; J Townsend
Journal:  Lancet       Date:  1970-11-21       Impact factor: 79.321

3.  Bronchodilator effect of oral salbutamol in asthmatics treated with corticosteroids.

Authors:  S S Parker; Y F Choo-Kang; E J Cooper; S J Cameron; I W Grant
Journal:  Br Med J       Date:  1971-10-16
  3 in total
  10 in total

1.  Comparison of intravenous aminophylline and salbutamol in severe asthma.

Authors:  S J Williams; R W Parrish; A Seaton
Journal:  Br Med J       Date:  1975-12-20

2.  Characterization of beta-adrenoceptor subtype mediating the metabolic actions of salbutamol.

Authors:  N Berend; G E Marlin
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

3.  Effect of intravenous injection of salbutamol in asthma.

Authors:  I W Grant
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

4.  Treatment of acute asthma: effect of intravenous corticosteroids and beta 2-adrenergic agonists.

Authors:  A Arnaud; D Vervloet; P Dugue; J Orehek; J Charpin
Journal:  Lung       Date:  1979       Impact factor: 2.584

5.  Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma.

Authors:  P Lawford; B J Jones; J S Milledge
Journal:  Br Med J       Date:  1978-01-14

6.  Intravenous or inhaled salbutamol in severe acute asthma?

Authors:  S Williams; A Seaton
Journal:  Thorax       Date:  1977-10       Impact factor: 9.139

7.  Effect of intravenous injection of salbutamol in asthma.

Authors:  C S May; J W Paterson; S G Spiro; A J Johnson
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

8.  Intramuscular salbutamol in treatment of acute exacerbations of childhood asthma.

Authors:  P Thompson; M Friedman
Journal:  Arch Dis Child       Date:  1977-07       Impact factor: 3.791

9.  Comparison of salbutamol given intravenously and by intermittent positive-pressure breathing in life-threatening asthma.

Authors:  P Bloomfield; J Carmichael; G R Petrie; N P Jewell; G K Crompton
Journal:  Br Med J       Date:  1979-03-31

10.  The effect of intravenously administered salbutamol on serum potassium in asthmatic and nonasthmatic atopic subjects.

Authors:  L Marazzini; A Pelucchi; M Bozzoni; B Mastropasqua; E Longhini
Journal:  J Clin Immunol       Date:  1985-05       Impact factor: 8.317
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.